Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 3151 AL 3165

Novel therapeutic strategies for Alzheimer's disease targeting brain cholesterol homeostasis

Samant NP, Gupta GL.

Eur J Neurosci. 2021 Jan;53(2):673-686. doi: 10.1111/ejn.14949. Epub 2020 Sep 18.

Repositioning medication for cardiovascular and cerebrovascular disease to delay the onset and prevent progression of Alzheimer's disease

Lee H, Kim E.

Arch Pharm Res. 2020 Sep;43(9):932-960. doi: 10.1007/s12272-020-01268-5. Epub 2020 Sep 9.

36-month LipiDiDiet multinutrient clinical trial in prodromal Alzheimer's disease

Soininen H, Solomon A, Visser PJ, Hendrix SB, Blennow K, Kivipelto M, Hartmann T; LipiDiDiet clinical study group.

Alzheimers Dement. 2021 Jan;17(1):29-40. doi: 10.1002/alz.12172. Epub 2020 Sep 13.

Can nicotinamide riboside protect against cognitive impairment?

Braidy N, Liu Y.

Curr Opin Clin Nutr Metab Care. 2020 Nov;23(6):413-420. doi: 10.1097/MCO.0000000000000691.

Drug repositioning and repurposing for Alzheimer disease

Ballard C, Aarsland D, Cummings J, O'Brien J, Mills R, Molinuevo JL, Fladby T, Williams G, Doherty P, Corbett A, Sultana J.

Nat Rev Neurol. 2020 Dec;16(12):661-673. doi: 10.1038/s41582-020-0397-4. Epub 2020 Sep 16.

Enhancing cognitive training effects in Alzheimer's disease: rTMS as an add-on treatment

Bagattini C, Zanni M, Barocco F, Caffarra P, Brignani D, Miniussi C, Defanti CA.

Brain Stimul. 2020 Nov-Dec;13(6):1655-1664. doi: 10.1016/j.brs.2020.09.010. Epub 2020 Sep 28.

Preliminary Evidence That Cortical Amyloid Burden Predicts Poor Response to Antidepressant Medication Treatment in Cognitively Intact Individuals With Late-Life Depression

Taylor WD, Boyd BD, Elson D, Andrews P, Albert K, Vega J, Newhouse PA, Woodward ND, Kang H, Shokouhi S.

Am J Geriatr Psychiatry. 2021 May;29(5):448-457. doi: 10.1016/j.jagp.2020.09.019. Epub 2020 Sep 28.

Therapeutic implications of hypothalamic-pituitaryadrenal-axis modulation in Alzheimer's disease: A narrative review of pharmacological and lifestyle interventions

Watermeyer T, Robb C, Gregory S, Udeh-Momoh C.

Front Neuroendocrinol. 2021 Jan;60:100877. doi: 10.1016/j.yfrne.2020.100877. Epub 2020 Oct 9.

Anti-Aβ agents for mild to moderate Alzheimer's disease: systematic review and meta-analysis

Lu L, Zheng X, Wang S, Tang C, Zhang Y, Yao G, Zeng J, Ge S, Wen H, Xu M, Guyatt G, Xu N.

J Neurol Neurosurg Psychiatry. 2020 Dec;91(12):1316-1324. doi: 10.1136/jnnp-2020-323497. Epub 2020 Oct 12.

Psychosis in Alzheimer's Disease

Ballard C, Kales HC, Lyketsos C, Aarsland D, Creese B, Mills R, Williams H, Sweet RA.

Curr Neurol Neurosci Rep. 2020 Oct 13;20(12):57. doi: 10.1007/s11910-020-01074-y.

Benfotiamine and Cognitive Decline in Alzheimer's Disease: Results of a Randomized Placebo-Controlled Phase IIa Clinical Trial

Gibson GE, Luchsinger JA, Cirio R, Chen H, Franchino-Elder J, Hirsch JA, Bettendorff L, Chen Z, Flowers SA, Gerber LM, Grandville T, Schupf N, Xu H, Stern Y, Habeck C, Jordan B, Fonzetti P.

J Alzheimers Dis. 2020;78(3):989-1010. doi: 10.3233/JAD-200896.

Cognitive effects and acceptability of non-invasive brain stimulation on Alzheimer's disease and mild cognitive impairment: a component network meta-analysis

Chu CS, Li CT, Brunoni AR, Yang FC, Tseng PT, Tu YK, Stubbs B, Carvalho AF, Thompson T, Rajji TK, Yeh TC, Tsai CK, Chen TY, Li DJ, Hsu CW, Wu YC, Yu CL, Liang CS.

J Neurol Neurosurg Psychiatry. 2021 Feb;92(2):195-203. doi: 10.1136/jnnp-2020-323870. Epub 2020 Oct 28.

Cognitive training and brain stimulation in prodromal Alzheimer's disease (AD-Stim)-study protocol for a double-blind randomized controlled phase IIb (monocenter) trial

Thams F, Kuzmina A, Backhaus M, Li SC, Grittner U, Antonenko D, Flöel A.

Alzheimers Res Ther. 2020 Nov 7;12(1):142. doi: 10.1186/s13195-020-00692-5.

Effects of Hippeastrum reticulatum on memory, spatial learning and object recognition in a scopolamine-induced animal model of Alzheimer's disease

Hoang THX, Ho DV, Van Phan K, Le QV, Raal A, Nguyen HT.

Pharm Biol. 2020 Dec;58(1):1098-1104. doi: 10.1080/13880209.2020.1841810.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias